SCIENTIFIC ADVISORY BOARD OF BIOPC2025
Alain Beck
Senior Director, Biologics CMC & developability
Institut de Recherche Pierre Fabre, France
Roland Beliard
ex-Business Development Director
ex-LFB Biomanufacturing, France
Nicola Beltraminelli
Chief Development Officer
Innate Pharma, France
Hervé Broly
ex-VP Biotech Process Development
ex-Merck Serono, Switzerland
Cédric Charretier
Global Head Vaccine Drug Substance Development, Vaccine CMC Development Supply
Sanofi, France
Olivier Cochet
Head of Biotech Developpment and Supply
Debiopharm, Switzerland
Arnaud Delobel
R&D Director Strategy & Innovation
Quality Assistance, Belgium
Sophie Derenne
Head of the Department Analysis and Market Development
Etablissement Français du Sang (EFS), France
Cyrille Chéry
Group Lead
UCB Pharma, Belgium
Michaël Lanero Fidalgo
Chief Operating Officer
TreeFrog Therapeutics, France
Oumeya (Mia) Adjali
Senior Scientist in Gene Therapy, Head of TaRGeT laboratory
INSERM, France
Nathalie Heuzé-Vourc'h
Research Professor Inserm, Deputy director "Health Technologies" Institute
INSERM, France
Miliza Diab
Upstream lab lead - MSAT
Novartis, France
John Churchwell
Associate Lead Scientist
Cell and Gene Therapy Catapult, UK
Guillaume Rousseau
MSAT Site lead
Sanofi, France
Hervé de Malliard
Chairman
MGA Technologies, France
Fabien Rousset
Director of Innovation
PolyPeptide Group, France
Kim Wilson
Business Value Expert - Life Sciences
Dassault Systèmes, USA